Kazuhito Sakata

Suggest Changes
Learn More
BACKGROUND In recent years, the establishment of new staging systems for hepatocellular carcinoma (HCC) has been reported worldwide. The system combining albumin-bilirubin (ALBI) with(More)
  • 1